emtricitabine has been researched along with Sensitivity and Specificity in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (52.94) | 29.6817 |
2010's | 7 (41.18) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chen, X; Geleziunas, R; Hesselgesser, J; Jin, H; Jones, GS; Kim, CU; Tsiang, M; Wright, M; Yu, F; Zeynalzadegan, A | 1 |
Baeten, JM; Defechereux, P; Deutsch, M; Gandhi, M; Glidden, DV; Grant, RM; Mugo, NR; Ngure, K; Okochi, H; Rodrigues, WC; Spinelli, MA; Stalter, R; Vincent, M; Wang, G | 1 |
Amara, A; Diliiy Penchala, S; Else, L; Khoo, S; Lamorde, M; Olagunju, A; Waitt, C | 1 |
Bärnighausen, TW; Geldsetzer, P; Gómez-Olivé, FX; Harling, G; Kahn, K; Manne-Goehler, J; Montana, L; Rohr, J; Siedner, M; Tollman, S; Wagner, R; Wiesner, L | 1 |
Baltussen, R; Boucher, CA; Nichols, BE; Nouwen, JL; Sloot, PM; Thuma, PE; van de Vijver, DA; van de Wijgert, J; van Dijk, JH | 1 |
Amancha, PK; Ansari, AA; Blanchard, EL; Byrareddy, SN; Connor-Stroud, F; Gumber, S; Hong, JJ; Hoxie, JA; Hunter, E; Rogers, KA; Santangelo, PJ; Schuster, DM; Strait, K; Vidakovic, B; Villinger, F; Zurla, C | 1 |
Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
Baietto, L; Bonora, S; D'Avolio, A; Di Perri, G; Gonzalez de Requena, D; Sciandra, M; Siccardi, M | 1 |
Gomes, NA; Joshi, SS; Parekh, SA; Pudage, A; Vaidya, VV | 1 |
Adams, E; Ashenafi, D; Hoogmartens, J; Verbeek, A | 1 |
Bushman, L; Delahunty, T; Fletcher, CV; Robbins, B | 1 |
Goswami, S; Pande, UC; Sanyal, M; Shrivastav, PS; Singhal, P; Yadav, M | 1 |
Anderson, PL; Bushman, LR; Kiser, JJ; Klein, B; Ray, ML; Rower, JE; Zheng, JH | 1 |
Crutchley, RD; Kashuba, AD; Rezk, NL | 1 |
Beijnen, JH; Prins, JM; Schellens, JH; Sparidans, RW | 1 |
Chandrasekhar, KB; Haribabu, B; Seshachalam, U | 1 |
Chan, HL; Lau, TC; Leung, NW; Sung, JJ; Wong, ML | 1 |
2 trial(s) available for emtricitabine and Sensitivity and Specificity
Article | Year |
---|---|
Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
Topics: Adenine; Adult; Anti-Retroviral Agents; Chromatography, Liquid; Cross-Over Studies; Deoxycytidine; Drug Stability; Emtricitabine; Humans; India; Lamivudine; Least-Squares Analysis; Male; Middle Aged; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Therapeutic Equivalency | 2010 |
Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy.
Topics: Antiviral Agents; DNA, Viral; Emtricitabine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Nucleic Acid Hybridization; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Zalcitabine | 2000 |
15 other study(ies) available for emtricitabine and Sensitivity and Specificity
Article | Year |
---|---|
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
Topics: Anti-HIV Agents; Catalytic Domain; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Synergism; HIV Integrase; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Molecular Structure; Mutation; Protein Structure, Tertiary; Recombinant Proteins; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; T-Lymphocytes | 2009 |
Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse Populations.
Topics: Adult; Anti-HIV Agents; Antibodies; Drug Combinations; Drug Monitoring; Emtricitabine; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; Humans; Kenya; Laboratories; Male; Patient Compliance; Point-of-Care Testing; Sensitivity and Specificity; Tenofovir; Uganda | 2020 |
Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Chromatography, Liquid; Cohort Studies; Dried Blood Spot Testing; Emtricitabine; Female; Humans; Infant; Lamivudine; Linear Models; Milk, Human; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir; Young Adult | 2017 |
ART Denial: Results of a Home-Based Study to Validate Self-reported Antiretroviral Use in Rural South Africa.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Cohort Studies; Emtricitabine; Female; HIV Antibodies; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Rural Population; Self Report; Sensitivity and Specificity; Social Stigma; South Africa; Surveys and Questionnaires; Viral Load | 2019 |
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.
Topics: Adenine; Anti-HIV Agents; Cost-Benefit Analysis; Deoxycytidine; Emtricitabine; HIV Infections; HIV-1; Humans; Models, Biological; Organophosphonates; Prevalence; Primary Prevention; Rural Population; Sensitivity and Specificity; Sexual Behavior; Tenofovir; Zambia | 2013 |
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.
Topics: Adenine; Animals; Anti-Retroviral Agents; Copper Radioisotopes; Deoxycytidine; Emtricitabine; Immunohistochemistry; Male; Membrane Glycoproteins; Naphthyridines; Organophosphonates; Positron-Emission Tomography; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Simian Immunodeficiency Virus; Tenofovir; Viral Envelope Proteins; Viremia; Virus Replication; Whole Body Imaging | 2015 |
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors | 2016 |
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
Topics: Adenine; Anti-HIV Agents; Calibration; Chromatography, Liquid; Deoxycytidine; Emtricitabine; HIV Infections; Humans; Organophosphonates; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tenofovir | 2008 |
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study.
Topics: Adenine; Calibration; Chromatography, Liquid; Deoxycytidine; Drug Combinations; Drug Stability; Emtricitabine; Humans; Organophosphonates; Practice Guidelines as Topic; Quality Control; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Tenofovir; Therapeutic Equivalency; Time Factors | 2008 |
Development and validation of an LC method for the determination of emtricitabine and related compounds in the drug substance.
Topics: Chromatography, Liquid; Deoxycytidine; Emtricitabine; Molecular Conformation; Sensitivity and Specificity; Stereoisomerism; Time Factors; Ultraviolet Rays | 2009 |
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
Topics: Adenine; Anti-HIV Agents; Chromatography, High Pressure Liquid; Deoxycytidine; Drug Stability; Emtricitabine; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tandem Mass Spectrometry; Tenofovir | 2009 |
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
Topics: Adenine; Anion Exchange Resins; Antiviral Agents; Calibration; Chromatography, Liquid; Deoxycytidine; Diphosphates; Emtricitabine; Humans; Lamivudine; Leukocytes, Mononuclear; Nucleosides; Organophosphonates; Phosphates; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry; Tenofovir; Zidovudine | 2011 |
Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction.
Topics: Adenine; Chromatography, High Pressure Liquid; Deoxycytidine; Drug Stability; Emtricitabine; Humans; Organophosphonates; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Tenofovir | 2005 |
Liquid chromatography-tandem mass spectrometric assay for the nucleoside reverse transcriptase inhibitor emtricitabine in human plasma.
Topics: Chromatography, Liquid; Deoxycytidine; Emtricitabine; Humans; Molecular Structure; Reference Standards; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance.
Topics: Chromatography, High Pressure Liquid; Deoxycytidine; Drug Contamination; Emtricitabine; Molecular Structure; Pharmaceutical Preparations; Sensitivity and Specificity; Stereoisomerism | 2007 |